Trastuzumab Completed Phase N/A Trials for Breast Cancer / Cardiac Toxicity

CompletedNot AvailableNot Available IdentifierTitleDrugs
NCT01152606A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
NCT03390608Prognostic and Predictive Factors for Small Breast Tumors
NCT02658461An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)
NCT01480674An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
NCT01894711Real World Efficiency of Trastuzumab in Early Breast Cancer
NCT00968682CADY Study ICORG 08-01